Yes, page-4

Yes i am in for the full amount.
You no doubt have worked the numbers and realize that if 67 shareholders take up 75,000 shares each, then that triggers a scale back in the allocations.
Only residents in Australia, New Zealand and the United Kingdom can participate. The KZIA holders are excluded.
AU$0.40 share price is super cheap for our drug Paxalisib about to enter a Phase 111 pivotal registration trial for Glioblastoma, but wait you pay for one trial and get the other brain cancer trials thrown in for a pittance.
And yes needle your Kazia valuations are realistic.

Regards.